/PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from its TRILUMINATE Pivotal trial that show the TriClip transcatheter edge-to-ed...
CardioVascular Technologies Competitors or Alternatives
CardioVascular Technologies's top competitors include Winifred S. Hayes, Inc., Abiomed and Abbott.
CardioVascular Technologies VS Winifred S. Hayes, Inc.
Winifred S. Hayes, Inc. is the top competitor of CardioVascular Technologies. Winifred S. Hayes, Inc. is a Private company that was founded in Lansdale, Pennsylvania in 1989. Like CardioVascular Technologies, Winifred S. Hayes, Inc. also operates in the Health Care Equipment & Services sector. Winifred S. Hayes, Inc. has 114 more employees vs. CardioVascular Technologies.
CardioVascular Technologies VS Abiomed
Abiomed is seen as one of CardioVascular Technologies's biggest rivals. Abiomed was founded in Danvers, Massachusetts} in 1981. Like CardioVascular Technologies, Abiomed also competes in the Health Care Equipment & Services space. Compared to CardioVascular Technologies, Abiomed generates $1.1B more revenue.
CardioVascular Technologies VS Abbott
Abbott is perceived as one of CardioVascular Technologies's biggest rivals. Abbott was founded in 1888, and is headquartered in Abbott Park, Illinois. Like CardioVascular Technologies, Abbott also operates in the Health Care Equipment & Services space. Abbott generates $41.9B more revenue vs. CardioVascular Technologies.
Looking for similar companies to CardioVascular Technologies?
Similar Companies
Health Care Equipment companies in Palo Alto
See 31 companies
Health Care Equipment companies in San Francisco Bay AreaSee 771 companies
Health Care Equipment & Services companies in Palo AltoSee 291 companies
Companies in Palo Alto with revenue in $5.0-25M rangeSee 1,513 companies
Companies in Palo Alto with employees in 25-100 rangeSee 1,952 companies
Health Care Equipment companies in CaliforniaSee 2,365 companies
Health Care Equipment companies with employees in 25-100 rangeSee 7,113 companies
Health Care Equipment companies with revenue in $5.0-25M rangeSee 7,211 companies
Health Care Equipment & Services companies in San Francisco Bay AreaSee 9,437 companies
Trending News for CardioVascular Technologies and CardioVascular Technologies's Competitors
Medtronic Evolut TAVR: Exceptional Valve Performance At 5 Years In Low-Risk Aortic Stenosis Patients
(RTTNews) - Medtronic plc (MDT) announced data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut transcathet...
(Reuters) -Shares of Johnson & Johnson fell more than 4% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end tens of thou...
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate─...
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO ® , th...
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS......
Evolut TAVR system demonstrates durable outcomes and excellent valve performance in low-risk aortic stenosis patients....
Study investigators expect that J&J's combo drug can extend overall survival by at least a year over the current standard of care in certain NSCLC pati...
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...
Frequently Asked Questions about CardioVascular Technologies
Who are CardioVascular Technologies's top competitors?
CardioVascular Technologies's top 3 competitors are Winifred S. Hayes, Inc., Abiomed, Abbott.Who is similar to CardioVascular Technologies?
Winifred S. Hayes, Inc. is the most similar to CardioVascular Technologies. Abiomed and Abbott are also similar to CardioVascular Technologies.
Are CardioVascular Technologies and Winifred S. Hayes, Inc. competitors?
Yes, Winifred S. Hayes, Inc. is one of CardioVascular Technologies’s top competitors.